Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
(2018) described MOTS-c as a systemic insulin sensitizer that acts across multiple tissues, including skeletal muscle, adipose, and potentially the brain [7]
Monitoring patient response during the infusion is key to making necessary adjustments
Contaminant Testing: Look for reports on heavy metals, microbial load, and solvent residues (e.g., residual trifluoroacetic acid, or TFA)
By blocking NNMT, the compound is associated with preserved NAD+ levels and reduced fat storage, alongside improvements in cellular energy utilization and insulin sensitivity
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
